Antihyperglycemic and antidyslipidemic activities of the aqueous Salvia hispanica extract. - GreenMedInfo Summary
Antihyperglycemic and Antidyslipidemic Activities of the Aqueous Salvia hispanica Extract in Diabetic Rat.
Cardiovasc Hematol Agents Med Chem. 2021 Jan 12. Epub 2021 Jan 12. PMID: 33438569
AIMS: The study targeted to evaluate the antihyperglycemic activity of Salvia hispanica.
BACKGROUND: Salvia hispanica L. (Lamiaceae) is a medicinal plant with many beneficial properties on human health.
OBJECTIVE: This objective of the study was to investigate the antihyperglycemic effect of the aqueous extract of Salvia hispanica (S. hispanica) seeds and its capacity to improve lipid profile in normal and STZ-induced diabetic rats.
MATERIAL AND METHODS: The seed aqueous extract of S. hispanica (SHSAE) at a dose of 100 mg/kg was administered orally in normal and diabetic rats. The effect of oral SHSAE treatment on blood glucose and lipid levels during 15 days was assessed in normal and streptozotocin-induced diabetic rats. The oral glucose tolerance test (OGTT) was carried out. The antioxidant activity of SHSAE was also examined.
RESULTS: The decrease of glycemia in rats following the administration of the plant extract suggested that the studied extract possesses antidiabetic effect. The extract of S. hispanica produced hypolipidemic effect with a significant lowering effect on plasma total cholesterol levels and increase on HDL-cholesterol levels. SHSAE was also able to enhance glucose tolerance using OGTT. Moreover, SHSAE possess a potential antioxidant effect in vitro.
CONCLUSION: In conclusion, this study demonstrates the antihyperglycemic and antilipidemic effects of SHSAE in rats.